SLGL — Sol-Gel Technologies Ltd. catalysts
Next verified catalyst
2026-08-01 — Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face o · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on
Phase 3 · Gorlin Syndrome |
SLGL Sol-Gel Technologies Ltd. | Patidegib Topical Gel, Patidegib Topical |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|